Mallinckrodt Inc. Joins The Partnership at Drugfree.org to Launch The Medicine Abuse Project
9/25/2012 10:08:41 AM
ST. LOUIS--(BUSINESS WIRE)--Mallinckrodt, the pharmaceuticals business of Covidien (NYSE: COV), today joined The Partnership at Drugfree.org in launching The Medicine Abuse Project, a multi-year effort to raise awareness and curb the abuse of prescription medicine by teens and young adults. Beginning this week, the campaign aims to prevent half a million teens from abusing such medications over the next five years.
comments powered by